Steven B Feinstein

Learning objectives

• Recall the components of the ‘ominous octet’ & how they contribute to T2DM development
• Identify underlying facets of clinical inertia in T2DM care
• Describe how early adoption of intensive glycaemic control leads to better outcomes in T2DM
• Recall efficacy & the mode of action of various incretin-based treatments
• Adopt an early, intensive glucose-lowering strategy in appropriate individuals 
• Select appropriate incretin treatment & dosing regimens according to patient profiles 
• Identify individuals likely to gain cardiovascular benefit from GLP-1RAs 
• Select appropriate actions following adverse events from incretin-based treatments